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Abstract
Background: An abundance of literature is dedicated to research for the treatment of Attention Deficit Hyperactivity
Disorder (ADHD). Most, is in the area of pharmacological therapies with less emphasis in psychotherapy and
psychosocial interventions and even less in the area of complementary and alternative medicine (CAM).
The use of CAM has increased over the years, especially for developmental and behavioral disorders, such as ADHD.
60–65% of parents with children with ADHD have used CAM. Medical evidence supports a multidisciplinary approach
(i.e. pharmacological and psychosocial) for the best clinical outcomes. The Neuro Emotional Technique (NET), a branch
of Chiropractic, was designed to address the biopsychosocial aspects of acute and chronic conditions including non-
musculoskeletal conditions. Anecdotally, it has been suggested that ADHD may be managed effectively by NET.
Design/methods: A placebo controlled, double blind randomised clinical trial was designed to assess the effectiveness
of NET on a cohort of children with medically diagnosed ADHD.
Children aged 5–12 years who met the inclusion criteria were randomised to one of three groups. The control group
continued on their existing medical regimen and the intervention and placebo groups had the addition of the NET and
sham NET protocols added to their regimen respectively. These two groups attended a clinical facility twice a week for
the first month and then once a month for six months.
The Conners' Parent and Teacher Rating Scales (CRS) were used at the start of the study to establish baseline data and
then in one month and in seven months time, at the conclusion of the study. The primary outcome measures chosen
were the Conners' ADHD Index and Conners' Global Index. The secondary outcome measures chosen were the DSM-
IV: Inattentive, the DSM-IV:Hyperactive-Impulsive, and the DSM-IV:Total subscales from the Conners' Rating Scales,
monitoring changes in inattention, hyperactivity and impulsivity.
Calculations for the sample size were set with a significance level of 0.05 and the power of 80%, yielding a sample size of
93.
Discussion: The present study should provide information as to whether the addition of NET to an existing medical
regimen can improve outcomes for children with ADHD.
Trial registration: Australian New Zealand Clinical Trial Registration Number: ANZCTRN 012606000332527
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Background
There is an abundance of literature dedicated to research
for the treatment of Attention Deficit Hyperactivity Disor-
der (ADHD) [1-5]. Most of this research is in the area of
pharmacological therapies with less emphasis in psycho-
therapy and psychosocial interventions [6-8] and even
less in the area of complementary and alternative medi-
cine (CAM) [9,10].
The use of CAM therapies, has increased over the years,
especially for the developmental and behavioral disor-
ders, such as ADHD[9,11-14]. Approximately 60–65% of
parents with children diagnosed with ADHD have used
CAM therapies [9,11,13,15,16]. Despite varied definitions
of what constitutes a CAM therapy, most definitions of
CAM include chiropractic. Whilst there is a great deal of
research on spinal manipulation performed by chiroprac-
tors, there are very few studies to substantiate  the effect
chiropractic treatment has on children with ADHD
[17,18]. Most published articles are of case studies [19-21]
case series [18,22,23] and small cohort studies with sam-
ple sizes ranging up to N = 7 [24,25]. Of these, only three
are from peer-reviewed journals [19,20,24] regardless, all
of these provide a low level of evidence without the fol-
low-up of randomised controlled trials (RCT) to substan-
tiate findings.
Medical evidence supports a multidisciplinary approach
(i.e. pharmacological and psychosocial) for children and
adolescents diagnosed with ADHD for the best clinical
outcomes [1,3,7,8,26-32]. In fact, certain studies have
shown that the multidisciplinary approach produces
additional benefits in that there is greater satisfaction
amongst parents and teachers as this approach leads to
lower medication dosages for these children [29,33]. It is
well established that ADHD is a multi-factorial disorder,
having both psychological and social components, that
can have negative outcomes if not diagnosed and man-
aged effectively [1,7,8,26,34-36].
The best clinical outcomes are produced when an inte-
grated biopsychosocial approach is employed for children
with ADHD [27,37-39]. The Neuro Emotional Technique
(NET), a branch of Chiropractic, was designed to address
the biopsychosocial aspects of acute and chronic condi-
tions including non-musculoskeletal conditions [40].
Evidence suggests that 10–30% of children with ADHD
who have been prescribed stimulant medications, do not
show clinically significant outcomes, and others experi-
ence side-effects and need to discontinue their medica-
tions [26,31,32,41-43].
The most common side effects of stimulant medications
are appetite suppression, weight loss, sleep disturbances,
irritability, stomach aches, headaches, rashes, and occa-
sionally the development or aggravation of tics
[3,6,26,29,38,41,43,44].
For these children, additional strategies need to be imple-
mented in order to achieve a successful outcome [1,42].
Parents with children diagnosed with ADHD who have
had less than satisfactory outcomes with conventional
management are presenting to chiropractors looking for
alternative interventions. Anecdotally, it has been sug-
gested that ADHD may be managed effectively by NET.
There are published case studies on the use of NET for
conditions such as hypothyroidism [45], anovulation
infertility [46], polycystic ovary syndrome [47], separa-
tion anxiety disorder [48], a case series on cancer-related
traumatic stress symptoms [49] and a RCT for trigger
point sensitivity in chronic neck pain sufferers [50]. How-
ever, there is no validation at this time to substantiate the
use of NET for children with ADHD. As a result, the appli-
cation of NET to a cohort of children with medically diag-
nosed ADHD is being researched. It is important to
research an approach being used with a clinic population
for which it was not previously designed for nor tested on.
The purpose of this paper is to outline the methodology
for the RCT employing the CONSORT [51,52] checklist in
its design.
Objectives
The objectives of this research are to:
1. To determine whether the addition of the Neuro Emo-
tional Technique (a new biopsychosocial intervention),
to an existing medical regimen can improve clinical out-
comes (i.e. reduce inattention, hyperactivity and impul-
sivity) for children with medically diagnosed ADHD.
2. Furthermore, to determine the responses in the short
term (i.e. one month) and medium term (seven months).
Methods
Design
Ethics approved, registered, interdisciplinary, placebo
controlled, double blind, randomized clinical trial.
Settings
Four private clinics in Sydney, Australia.
Care providers
Four chiropractors, three male and one female volun-
teered their time and services to administer interventions
to the participants of the study at no cost. The chiroprac-
tors had varied tertiary qualifications: one had Bachelor of
Medical Sciences and a Master of Chiropractic; two had a
Bachelor of Science and a Master of Chiropractic and one
had Bachelor of Science and a Graduate Diploma of Chi-Trials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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ropractic. All of the chiropractors had undergone the four
NET training workshops over a two year period, and had
passed the certification exams in both theory and practice,
and a thus were qualified as NET certified practitioners.
These practitioners were chosen on the basis that they
were experts in the field, were certified and agreed to abide
by the study protocols.
Participants
Parents were initially screened on the phone, and their
children were included in the study if inclusion criteria
were met. Inclusion criteria comprised: children aged
between 5–12 years; children with a medical diagnosis of
ADHD for minimum of 2 months, diagnosed by Pediatri-
cian, Psychiatrist or Clinical Psychologist; informed ver-
bal and written consent from parents and participants;
children currently undergoing any interventions (phar-
macological, psychosocial therapy, educational, occupa-
tional therapies etc) or children with the diagnosis of
ADHD who have not undergone any treatment; and chil-
dren who presented with the following comorbid disor-
ders – Conduct Disorder, Oppositional Defiant Disorder,
Learning Disabilities, and Anxiety Disorders. Any children
who did not meet the inclusion criteria, or who met the
exclusion criteria were excluded from the study. Exclusion
criteria comprised: A diagnosis of Language difficulties,
Mood Disorders (eg. Depressive Disorder or Bipolar Dis-
order), Communication Disorder, mutism, Pervasive
Developmental Disorder (eg. Autism or Asperger's Disor-
der), Psychosis, profound deafness and other physical or
mental disabilities that would prevent participants inter-
acting physically and verbally with the care provider dur-
ing the consultation; any changes in medications during
the course of the study, and any child or parent who had
previously undergone any NET treatment.
Measures
The Diagnostic and Statistical Manual of Mental Disorders
ADHD diagnostic criteria [53,54] were used by the partic-
ipants' Pediatricians and Clinical Psychologists to estab-
lish a diagnosis. The reliable and validated Conners'
Parent Rating Scales-Revised Long Version (CPRS-R:L)
and Conners' Teacher Rating Scales-Revised Long Version
(CTRS-R:L) [55-59] were used pre and post intervention.
The ratings scales were administered pre-intervention to
establish baseline data, and were used as outcome assess-
ments to measure the intervention effects at the end of the
first month and at the conclusion of the study i.e. in seven
months. Of the 14 subscales described in the CPRS-R:L
and the 13 subscales described in the CTRS-R:L, two were
chosen as primary outcome measures (POMs) and three
were chosen as secondary outcome measures (SOMs). Pri-
mary outcome measures included Conners' ADHD Index
and Conners' Global Index Total subscales H and K
respectively. The secondary outcome measures included
DSM-IV:Inattentive, DSM-IV:Hyperactive-Impulsive and
DSM-IV:Total, subscales L, M, and N respectively.
Primary Outcome Measures
The Conners' ADHD Index is used to distinguish ADHD
children from non-clinical children, and is considered a
good screening tool [55,59]. The Conners' Global Index
(CGI) is valuable in assessing general psychopathology
and for monitoring treatment effectiveness and changes
over time. It is sensitive to treatment changes for repeated
measures [55,56]. It reflects general behavioral problems,
including hyperactivity and attentional difficulties.
Secondary Outcome Measures
The DSM-IV:Inattentive subscale was chosen as it has a
correlation with the DSM-IV diagnostic criteria for the
Inattentive Subtype of ADHD, and focuses on the symp-
tom of inattention. The DSM-IV:Hyperactive-Impulsive
subscale was chosen as it has a correlation with the DSM-
IV diagnostic criteria for the Hyperactive-Impulsive Sub-
type of ADHD, and focuses on the symptoms of hyperac-
tivity and impulsivity. The DSM-IV:Total subscale was
chosen as it has a correlation with the DSM-IV diagnostic
criteria for the Combined Subtype of ADHD, and focuses
on all core features of ADHD (i.e. inattention, hyperactiv-
ity and impulsivity) [55].
Treatment allocation
Eligible participants were randomly allocated to one of
three groups A, B, & C (i.e. group A-sham, group B-treat-
ment, and group C-control). The "QuickCalcs" program
from the GraphPad Software [60] was used to randomly
sequence 150 numbers (repeated 1×) into the three
groups.
Each number and its randomised letter (A, B, or C) were
placed in an opaque envelope. Each envelope was num-
bered consecutively from 1–150.
As each parent called to have their child screened they
were allocated the next consecutive number once they
were eligible, so that eligible participant no. 1 was allo-
cated to envelope no. 1, etc. The screener was unaware of
the sequence of group allocation at the time of screening,
hence allocation was concealed at time of recruiting.
Blinding
Participants were blinded as to which intervention group
they were allocated to, in an attempt to control for the
Hawthorne Effect. Parents and teachers were blinded to
which intervention group the children were allocated to,
in an attempt to minimize rater bias when completing rat-
ing scales i.e. CPRS-R:L and CTRS-R:L. The registered Psy-
chologist and the Clinical Psychologist were blinded as toTrials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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which group participants were allocated to, in order to
minimize bias when scoring and interpreting the data
from the CPRS-R:L and CTRS-R:L.
The NET practitioners were not blinded in this study as
they needed to know which participants were receiving
which intervention, i.e. treatment versus sham protocol.
The parents of the control group were also aware that their
children were in the control group awaiting treatment at
the completion of the study.
Sample size justification
Calculations for the sample size were set with a signifi-
cance level of 0.05 and the power of 80%.
As there are no prior studies conducted in the area of chi-
ropractic or NET for an ADHD cohort, for power analysis
purposes a SD of 6.7 was adopted based on data from
Shortt [61], yielding a sample size of 63. The value of 6.7
for power testing is supported by findings from a paper on
the meta-analysis of RCTs in ADHD responses to atomox-
etine using the CRS [62]. This study revealed an average
SD score of 6.7, which is consistent with the SD found in
the Shortt data [61]. In a meta-analysis of psychotherapy
dropouts the mean attrition rate was 46.86% [63,64].
Based on this drop-out rate it was prudent to increase the
sample size by this figure, increasing it from 63 to n = 93.
Recruitment
Recruitment for the study commenced in July 2006 and
the first participant was enrolled in August 2006 and the
last participant completed the study in March 2008. Each
participant that qualified and was enrolled into the study
and had their own start date, hence the staggered starts
and as a result the study took 17 months to complete.
Withdrawals
As part of the phone screening and the informed consent
forms the parents of the participants were advised that
they were free to withdraw their child/children from the
study at any stage without any consequences.
Protocol
Group A, the sham group, continued with their existing
program and the sham protocol was added to their regi-
men. Group B, the treatment group, continued with their
existing program and the NET protocol was added to their
regimen. The participants in groups A and B attended a
clinical facility for the first month and received eight treat-
ments (two treatments per week) for approximately 15–
20 minute sessions. Then, they were scheduled for
another six treatments over the next six months (i.e. one
treatment per month). Group C, the control group, con-
sisted of children who continued with their existing
ADHD treatment regimen as prescribed by their pediatri-
cian, clinical psychologist and/or medical doctor.
Neuro Emotional Technique (NET) protocol
Definition of NET
NET is a methodology of finding and removing Neuro
Emotional Complexes (NECs). A NEC is defined as a sub-
jective maladaptation syndrome adopted by the organism
in response to a real or perceived threat to any aspect of its
survival [40]. NET has been described as a treatment
designed to address negative distressing stimuli, by
removing these patterns by accessing the nervous system
via stimulation of the spine.
Walker [40] described NET as a 15 step (Figure 1), multi-
modal system that integrates the principles of several
health modalities, including cognitive behavioural psy-
chology principles, traditional Chinese pulse assessment,
acupuncture theory and the feedback technique called
muscle testing.
Muscle testing is non-invasive system of evaluating the
function of the body [65]. NET protocol uses muscle test-
ing throughout the procedure as an indicator for physio-
logic reactivity to a protocol of statements designed to
challenge the cognitive recall of stimuli under contempla-
tion [66].
NET is a system that evaluates structural, emotional, and
chemical (i.e. toxic and nutritional) aspects of a patient's
health and wellbeing using the manual muscle testing
procedure as a diagnostic guide. Emphasis must be made
that for the purpose of this study, the emotional aspects
were the only issues addressed, investigating whether ones
"emotional reality" affected one's mental wellbeing and
behaviour patterns.
NET protocol
Firstly, the participants were evaluated for a healthy del-
toid muscle, capable of resisting the testing pressure of the
practitioner. The participants were seated, and asked to
raise their arm 90 degrees to their body, keeping their
elbow straight. Pressure was applied to the participant's
wrist, whilst they were asked to "hold strong", (i.e. resist
pressure). A practice trial was conducted to familiarize the
participants with muscle testing procedure (MTP). This
MTP has shown good inter-examiner reliability [67].
The participants were asked to make the following state-
ment, "I'm OK, keeping still."
If MTP to this statement tested weak, it is said that the par-
ticipant is non-congruent with that concept.
Next, the participants were asked to continually repeat
that statement whilst the practitioner continued the MTP
with one hand and with the other hand palpated the dif-
ferent meridian access points (MAPs) on the participant's
body. Each MAP is considered to be a specific skin pointTrials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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which, based on acupuncture theory is associated with
certain emotions [68]. (Figure 2 and 3)
When the participants tested strong to the statement and
a MAP, it was considered that there was an emotional
component related to their problem.
The practitioner continued to explore the psychosomatic
connection by making a series of statements. Using the
MTP the concept of an "original event" was being investi-
gated. The current "emotion" was related to a past event
by the asking of "when, where, and who" questions. This
was done to uncover why there appeared to be retained
conditioned response to a previous stressful event.
The untested theory of NET suggests that the stimuli asso-
ciated with the original event become associated via a
process of Pavlovian conditioning, and are then repro-
duced through a process of repetition compulsion.
The participants were provided a statement that con-
nected past and present events relating to their "emotion".
If the MTP using this statement, tested weak, it indicated
that the problem had been recalled.
Next, the participants were asked to contemplate the orig-
inal event and associated feelings in the conscious mind,
and were given kinaesthetic stimulation of spinal seg-
ments. The conscious recall of past events with the associ-
ation of normalised stimuli is theorised to condition the
original event with positive stimuli. This is believed to
break the cycle of the conditioned (learnt) response by
reactivating the original negative event and it's ongoing
repetition and pairing it with a competing somatic stimu-
lus.
Lastly, the practitioner retested the participant by using
MTP to check the original statement "I'm OK keeping
still". When the MTP tests strong, this indicates the partic-
ipant is now congruent with that statement.
15-step NET protocol Figure 1
15-step NET protocol.Trials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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This procedure was repeated using 16 different referential
statements. During the first month of treatment two refer-
ential statements per visit were used and tested. If the MTP
tested weak, implying the participant was not congruent
with the concept in that particular statement, then the
NET protocol ensued. Please see Table 1 for a complete list
of statements used. The statements were designed by the
primary investigator in consultation with an expert NET
practitioner and the study supervisors using the DSM-IV
criteria which are used to diagnose ADHD and coupled
them with the standard 15 step NET protocol (Figure 1),
designed by Walker [40]. Another explanation of this pro-
tocol is described in a study published by Bablis and col-
leagues [50].
Sham NET protocol
The sham protocol was designed to mimic the real NET
treatment protocol, however without the therapeutic ben-
efits. The sham protocol incorporated the MTP through-
out the procedure, with different sets of statements and
tapping on the back. The set of statements used were not
related to the treatment protocol, but instead used for test-
ing of congruent and non-congruent reactions to state-
ments like, " my name is John" and then "my name is
Robert" i.e. the child's name first then another name. See
Table 2 for a complete list of the first Sham protocol. In
total eight different sham protocols were designed with
different lists of referential statements.
Risks
As there are no known side effects and there have not been
any reports of adverse reactions to the NET protocol, we
do not anticipate that any participants will be exposed to
any unnecessary risks. However, in the event that a child
becomes emotionally distressed during the protocol, the
procedure will be terminated. Support counselling will be
offered by qualified psychotherapists and counsellors for
the child at no expense to the parents. These professionals
have all been approved for the study by the university Eth-
ics Committee and have also undergone background
screening and have been approved to work with children.
Ethics review
The trial protocol was reviewed by the Macquarie Univer-
sity Human Ethics Committee (Sydney, Australia) and
was granted Human Ethics Approval (HE26AUG2005-
M04261). As a prerequisite to conducting research with
children, the Ethics committee required all those involved
with the study undergo background screening as part of
the "Working With Children Check". All those involved in
the study were approved and ethics was granted.
Furthermore, as part of this study, an application was
made to the Department of Education and Training and a
State Education Research Approval was granted (SERAP
#06.350). This enabled the researchers to send question-
naires to the teachers of the participants of the study.
Informed consent
All of the parents of the participants were issued with two
copies of the informed consent forms (one to keep and one
to return to the university). The informed consent form
conveyed the following information: the names of the chief
investigator, the supervisors and the four practitioners
administering the interventions; the name of the university
and the department conducting the research; a brief
description of the control, treatment and sham groups; the
duration of the study; the questionnaires used; the Ethics
approval and contact details of the Ethics officer; the right
to withdraw their child at any time; in the event a child
becomes distressed the back-up counselling services availa-
ble; the involvement of teachers; and the fact that the
results of the study will be disseminated via conferences
and publications whilst maintaining the children's privacy.
Analysis
Demographic and baseline characteristics of participant
variables will be compared between the three randomised
groups using the Restricted Maximum Likelihood (REML)
in GenStat 10th Edition [69].
NET Body Meridian Access Points (MAPs) Figure 2
NET Body Meridian Access Points (MAPs).Trials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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Simplified Master NET Chart outlining Meridians/Organs; Subluxation sequences; Emotions; NET Remedies Figure 3
Simplified Master NET Chart outlining Meridians/Organs; Subluxation sequences; Emotions; NET Remedies.Trials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
Page 8 of 11
(page number not for citation purposes)
The primary analysis will compare outcomes for each pri-
mary and secondary outcome measure between the three
groups (treatment, sham and control) using the Restricted
Maximum Likelihood (REML) in GenStat 10th Edition
[69], to estimate treatment effect with 95% CI. REML is a
method for fitting mixed linear models (the models for
ANOVA being special cases) which can produce unbiased
(or less biased) estimates of variance and covariance
parameters. This is a relatively new and powerful tech-
nique that allows for data sets that are unbalanced, have
missing values, have treatments with unequal variances
and/or have correlated error terms [70].
An intention-to-treat (ITT) analysis will be undertaken of
the one month and seven month data from the CPRS-R:L
and CTRS-R:L for the participants who commenced the
study but did not complete.
Discussion
We have a presented the design and the protocol for the
RCT of NET for childhood ADHD. The participants of this
study will have NET added to their existing medical regi-
men (pharmacologic and/or psychosocial) and will be
monitored for changes in their outcomes (i.e. inattention,
hyperactivity and impulsivity) in the short term (one
month) and medium term (7 months). Completion of
this trial will help provide the answer to the question
"does chiropractic (NET) have a role to play in the man-
agement of children with ADHD?" Results of this RCT will
be disseminated at the completion of the study.
Abbreviations
NET: Neuro Emotional Technique; ADHD: Attention Def-
icit Hyperactivity Disorder; CAM: Complementary and
Alternative Medicine; CONSORT: Consolidated Standard
of Reporting Trials; DSM-IV: Diagnostic and Statistical
Table 1: List of referential statements used in NET protocol for treatment group B.
Referential statements Muscle testing procedure (MTP)
Non-congruent (weak muscle) Congruent (strong muscle)
I'm OK having ADHD
I'm OK keeping still
I'm OK listening to authority
I'm OK waiting my turn
I'm OK thinking one thing at a time
I'm OK thinking before doing
I'm OK remembering what I'm told
I'm OK finishing what I start
I'm OK doing homework
I'm OK doing class work
I'm OK listening to the teacher
I'm OK doing school work
I'm OK thinking before talking
I'm OK staying in my seat
I'm OK having quiet time
I'm OK going to sleep at bedtimeTrials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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Table 2: List of referential statements used in sham protocol for sham group A.
Referential statements for sham Muscle Test
Weak Strong
My name is .......... (insert child's name)
My name is .......... (make up wrong name)
My age is ............ years (insert child's age)
My age is ............ years (insert wrong age)
I live in ............... (insert child's suburb)
I live in .............. (insert wrong suburb)
Today is ............. (insert the name of today)
Today is ............. (insert the wrong day)
My hair colour is .... (insert colour of child's hair)
My hair colour is .... (insert wrong colour of child's hair)
My eye colour is .... (insert colour of child's eyes)
My eye colour is .... (insert wrong colour of child's eyes)
I am in ............... class at school (insert child's class)
I am in ............... class at school (insert wrong class)
I go to ................ (insert name of child's school)
I go to ................ (insert name of wrong school)
My teachers name is .... (insert name of teacher)
My teachers name is ... (insert wrong name of teacher)
My favourite sport is ... (insert name of favourite sport)
My favourite sport is ... (insert name of wrong sport)
My favourite subject at school is ... (insert favourite subject)
My favourite subject at school is ... (insert wrong subject)
My worst subject at school is ... (insert worst subject)
My worst subject at school is ... (insert different subject)
My best friend is ... (insert name of best friend)
My best friend is ... (insert wrong name)Trials 2009, 10:6 http://www.trialsjournal.com/content/10/1/6
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Manual of Mental Disorders 4th Edition; CRS: Conners'
rating Scales; CPRS-R:L: Conners' Parent Rating Scale
Revised Long Version; CTRS-R:L: Conners' Teacher Rating
Scale Revised Long Version; POMs: Primary Outcome
Measures; SOMs: Secondary Outcome Measures; CGI:
Conners' Global Index; CBT: Cognitive Behavioral Ther-
apy; NECs: Neuro Emotional Complex; MTP: Muscle Test-
ing Procedure; SERAP: State Education Research Approval;
ANOVA: Analysis of Variance; ITT: Intention-to-Treat
Analysis; CI: Confidence Intervals; RCT: Randomized
Controlled Trial.
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